Open help menu
Live Webinar

Navigating Unchartered Waters: The Perils and Promise of GLP-1's in Patients with Eating Disorders

|

Information

Date & Time

Learning Objectives

Participants will be able to:

  • Identify the FDA indications for use of currently available GLP-1 and glipron medications.

  • Explain the limits of current studies examining GLP-1 use in patients with ED.

  • Incorporate standard screening and monitoring practices to mitigate risk of causing harm to patients with ED who are prescribed GLP-1 medications.

Educational Goal

The educational goal of this educational activity is to increase knowledge of the risks, limits and potential benefits of GLP-1 medications in patients with eating disorders.

Description

While GLP-1 medications now carry FDA approval for and widespread clinical use across a range of medical conditions, there is limited research examining their use in patients with eating disorders. This presentation will review currently available GLP medications, mechanism of action, and evidence base for use in diabetes control and weight management. The presenter will critically examine preliminary reports of these medications for treating addiction and binge eating from an eating disorder, health equity, weight inclusive and holistic lens. Practical tips to navigate risk/benefit discussions with patients, families and medical providers will be given based on our limited evidence base. Best clinical practice guideline given the limits of what we currently know will be offered.

Target Audience

  • Addiction Professional
  • Counselor
  • Dietitian
  • Marriage & Family Therapist
  • Nurse
  • Physician
  • Physician Assistant
  • Psychologist
  • Social Worker

Presenters

Kim Dennis, MD, is a double board-certified psychiatrist (psychiatry and addiction medicine). She specializes in treating eating disorders, SUDs, food addiction, trauma, and complex co-occurring psychiatric disorders. She maintains a holistic and integrated treatment philosophy, incorporating the biological, psychological, social and spiritual approaches into trauma-informed, personalized treatment plans. She is the co-founder, Chief Medical Officer, and CEO of SunCloud Health. She obtained her medical degree from the University of Chicago, Pritzker School of Medicine, and completed her psychiatry residency training at the University of Chicago Hospitals, where she served as Chief Resident.  Dr. Dennis is a clinical assistant professor at the University of Illinois Chicago in the Department of Psychiatry. She serves as a member of NEDA’s Clinical Advisory Council, a member of the American Association of Pediatrics Eating Disorders and Obesity Workgroup, scientific advisory board member for ANAD, board member for Sero Mental Health and leads the research lab at SCH. Dr. Dennis regularly speaks on the intersection of trauma, medical comorbidities, eating disorders, substance use disorders and food addiction at conferences, on podcasts and webinars, locally, nationally and internationally. She brings lived experience to her work as a physician with long-term recovery from an eating disorder, food addiction, and trauma.

Financially Sponsored By

  • National Eating Disorders Association